Market Overview
The global single-use bioprocessing market was valued at USD 6.64 Billion in 2022 and is anticipated to reach USD 26.43 Billion by 2031, expanding at a robust CAGR of 16.59% during the forecast period (2023–2031). This growth is driven by the rising adoption of disposable technologies in biopharmaceutical production, cost-efficiency, and the increasing demand for personalized medicine.
Market Definition
Single-use bioprocessing involves the use of disposable bioprocessing equipment and accessories for manufacturing biopharmaceuticals. These technologies eliminate the need for traditional stainless-steel systems, reducing contamination risks, operational costs, and turnaround time.
Latest 3 Trends in the Single-use Bioprocessing Market:
- Increased Adoption of Single-use Systems in Cell and Gene Therapy: Single-use technologies are becoming integral to cell therapies and personalized medicines, ensuring flexible production with lower contamination risks.
- Technological Innovations in Single-use Equipment: New developments in sensors, bioreactors, and mixing systems are enhancing process efficiency.
- Sustainability Initiatives: Growing focus on eco-friendly solutions and recyclable bioprocessing systems to meet environmental standards.
Get a Full PDF Sample Copy of the Report: https://straitsresearch.com/report/single-use-bioprocessing-market/request-sample
Key Growth Factors
- Cost Efficiency: Single-use systems reduce cleaning, sterilization, and maintenance expenses compared to stainless-steel systems.
- Increasing Demand for Biopharmaceuticals: Rising production of monoclonal antibodies, vaccines, and cell therapies is driving the market.
- Reduced Risk of Cross-contamination: Single-use technologies minimize contamination risks, improving overall production quality and compliance.
Key Market Opportunities
- Growing RD Investments: Increasing investments in biotechnology and pharmaceutical research are boosting adoption.
- Emergence of Personalized Medicine: Expansion of precision therapies is creating significant demand for flexible single-use technologies.
- Expansion in Emerging Markets: High growth potential in developing regions like Asia-Pacific due to rising healthcare investments.
Market Segmentation
By Product
- Single-use Bioprocessing Equipment
- Simple and Peripheral Devices
By Applications
- Monoclonal Antibodies (mABs)
- Vaccines
- Cell Therapies
- Others
By End-Users
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
- RD Companies and Research Institutes
By Method
- Filtration
- Storage and Transport
- Cell Culture
- Mixing
- Purification
Access Detailed Segmentation: https://straitsresearch.com/report/single-use-bioprocessing-market/segmentation
Key Market Players
- Thermo Fisher Scientific
- Sartorius Stedim Biotech
- Parker-Hannifin Corporation
- Danaher
- Applikon Biotechnology
- Eppendorf
- CESCO Bioengineering
- Rentschler Biopharma SE
- Entegris
- Meissner Filtration Products
- Merck KGaA
- Avantor
Regional Insights
- Dominated Region: North America leads the market due to advanced infrastructure, significant biopharmaceutical production, and early adoption of disposable technologies.
- Fastest Growing Region: Europe is witnessing rapid growth, driven by increasing demand for sustainable bioprocessing solutions and rising RD activities.
For More Information or Query or Customization Before Buying, Visit: https://straitsresearch.com/buy-now/single-use-bioprocessing-market
About Straits Research
Straits Research is a global market research and consulting firm delivering data-driven insights and actionable strategies to help businesses make informed decisions.
Contact Us
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
